Viatrexx-Mesenchyme

Product NDC
63776-102
Requested package NDC
63776-102-17
11-digit product format
637760102
Labeler code
63776
Product ID
63776-102_e252cac0-f619-4707-9d81-aef02bda3ef2
Type
HUMAN OTC DRUG
Nonproprietary name
Adrenal, Ascorbic Acid, BDNF, DHEA, Malic acid, bFGF, Fucus vesiculosus, Histidine, Hyaluronidase, IL-6, Lactic acid, Lymph node, Mesenchyme, NAD, Natrum oxalaceticum, Natrum pyruvicum, Natrum sulphuricum, Phenylalanine, Amino Acid, Pyrogenium, Thuja occidentalis, Trichinoyl, Tyrosine
Dosage form
SPRAY
Route
ORAL; TOPICAL
Labeler
VIATREXX BIO INCORPORATED
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2019-03-29
Marketing end
0000-00-00
Substance
BOS TAURUS ADRENAL GLAND; SUS SCROFA ADRENAL GLAND; ASCORBIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN; PRASTERONE; MALIC ACID; BASIC FIBROBLAST GROWTH FACTOR (HUMAN); FUCUS VESICULOSUS; HISTIDINE; HYALURONIDASE; HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED); LACTIC ACID; SUS SCROFA LYMPH VESSEL; BOS TAURUS LYMPH VESSEL; SUS SCROFA MESENCHYME; NADIDE; SODIUM DIETHYL OXALACETATE; SODIUM PYRUVATE; SODIUM SULFATE; PHENYLALANINE; PROLACTIN; RANCID BEEF; THUJA OCCIDENTALIS LEAF; DODECAHYDROXYCYCLOHEXANE DIHYDRATE; TYROSINE
Active strength
200 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage63776-10263776-102-17IInactivated by FDA2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 16 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29fb8cb913e6d1…eb8c232b6be0…

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
980b5d64-e8e5-e1c9-b721-75e08f4e00a1Product name220200323
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
86ca2ee7-106a-420e-9137-a9ec1af5dbc1Product name120170110
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63776-102-11Viatrexx-Mesenchyme0.5 mL in 1 AMPULESPRAY0.51
63776-102-14Viatrexx-Mesenchyme30 mL in 1 BOTTLESPRAY301
63776-102-15Viatrexx-Mesenchyme50 mL in 1 BOTTLESPRAY501
63776-102-16Viatrexx-Mesenchyme100 mL in 1 BOTTLESPRAY1001
63776-102-17Viatrexx-Mesenchyme250 mL in 1 BOTTLESPRAY2501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63776-102VIATREXX-MESENCHYME (ADRENAL, ASCORBIC ACID, BDNF, DHEA, MALIC ACID, BFGF, FUCUS VESICULOSUS, HISTIDINE, HYALURONIDASE, IL-6, LACTIC ACID, LYMPH NODE, MESENCHYME, NAD, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NATRUM SULPHURICUM, PHENYLALANINE, AMINO ACID, PYROGENIUM, THUJA OCCIDENTALIS, TRICHINOYL, TYROSINE) SPRAY [VIATREXX BIO INCORPORATED]1Legacy NDC, 5 package rows20210217_fce9f82b-e995-4a91-ac56-72af500bc706.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63776-102-1763776010217250 mL in 1 BOTTLE (63776-102-17) 250 ml2019-03-290000-00-00NoNoCurrent